AstraZeneca, a global, science-led biopharmaceutical company, has announced the expansion of its state-of-the-art Global Hub in Bengaluru, strengthening its presence in India.
The new facility will house nearly 1300 employees, including 400 new jobs, supporting the company's capabilities in artificial intelligence (AI)-powered innovation across Research and Development, Global Business Services, IT, and Digital Health operations.
This announcement represents AstraZeneca's second major investment in India within a year, following the expansion of its Global Innovation and Technology Centre (GITC) in Chennai. The combined workforce now at AstraZeneca India Private Limited (AZIPL) will reach close to 4,000 employees, strengthening company's capability to deliver life-changing medicines to patients worldwide.
The new facility will serve as a dynamic hub dedicated to advancing AstraZeneca's critical priorities:
"AstraZeneca's investment reaffirms India's leadership in science, technology, and healthcare, and is a testament to Karnataka's robust life sciences ecosystem. This expansion aligns perfectly with our vision to create high-value employment opportunities while fostering innovation in critical sectors, making Bangalore a global hub for biotechnology and R&D," said Dinesh Gundu Rao, Minister of Health & Family Welfare, Government of Karnataka.
